Jornal Vascular Brasileiro is a prestigious Open Access journal published by the SOC BRASILEIRA ANGIOLOGIA CIRURGIA VASCULAR-SBACV and dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Since its inception in 2005, this Brazilian journal aims to provide a platform for sharing innovative research, clinical practices, and reviews that address the complexities of vascular health. With an ISSN of 1677-5449 and an E-ISSN of 1677-7301, it has emerged as a vital resource for researchers, practitioners, and students alike, despite its current positioning in the Q4 quartile for its category in 2023, reflecting a commitment to scholarly rigor and growth. The journal invites contributions on a wide range of topics, making it an essential reading for those involved in the academic study and clinical application of vascular medicine. As we look towards 2024, Jornal Vascular Brasileiro continues to bridge local and global perspectives, fostering collaboration and innovation in cardiovascular research and practice.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

PHLEBOLOGIE is an esteemed journal published by GEORG THIEME VERLAG KG, serving as a critical platform for the dissemination of research in the field of Cardiology and Cardiovascular Medicine. Since its inception in 1991, the journal has consistently provided a comprehensive range of articles that explore the complexities of vascular health, offering insights into innovative treatments, diagnostic advancements, and emerging trends. Although currently not available as an Open Access publication, PHLEBOLOGIE maintains an impactful presence in the academic community, evident in its 2023 Scopus ranking as Q3 within its category and a percentile standing of 25%. Residing in Germany, PHLEBOLOGIE aims to bridge the gap between research and practice, appealing to researchers, clinicians, and students alike by fostering a deeper understanding of vascular conditions and their management.

JOURNAL OF VASCULAR SURGERY, published by MOSBY-ELSEVIER, stands at the forefront of vascular and cardiovascular health research, contributing significantly to the advancement of surgical techniques and medical practices in its field. With a remarkable convergence from 1984 to 2024, this esteemed journal operates within the top tier, classified as Q1 in Cardiology and Cardiovascular Medicine as well as Q1 in Surgery for 2023, showcasing its impact and influence in scholarly discourse. Holding a prestigious rank of #20 out of 551 in Medicine–Surgery and #62 out of 387 in Medicine–Cardiology and Cardiovascular Medicine, the journal engages a wide audience of researchers, clinicians, and students dedicated to improving vascular health outcomes. While it currently does not offer open access, the Journal remains essential for professionals seeking to remain abreast of cutting-edge trends, methodologies, and comprehensive reviews across various vascular surgery domains. As it continues to shape practice through high-quality research and clinical findings, the JOURNAL OF VASCULAR SURGERY remains a critical resource for advancing knowledge and enhancing patient care.

Angiologia, published by ARAN EDICIONES, S A, serves as a vital platform for the dissemination of research and advancements in the fields of cardiology and cardiovascular medicine. Established in 1949, this Spanish journal has made significant contributions to understanding vascular health, although it currently holds a Q4 status in Scopus rankings, indicating a critical opportunity for emerging researchers to contribute to this evolving field. Spanning from 1949 to 1993 and resuming from 1996 to 2024, the journal reflects a rich history of academic discourse. With its ISSN 0003-3170 and E-ISSN 1695-2987, Angiologia is committed to enhancing the visibility of cardiovascular research, providing access to a diverse range of articles that cater to the needs of healthcare professionals, academics, and students aiming to deepen their understanding of angiological health. While the journal currently does not offer open access options, it remains significant in guiding future research and fostering innovations within the cardiology landscape.

PHLEBOLOGY is a renowned academic journal published by SAGE Publications Inc. that focuses on the evolving field of phlebology and related cardiovascular issues. With an ISSN of 0268-3555 and an E-ISSN of 1758-1125, this journal serves as a pivotal platform for disseminating high-quality research, clinical findings, and innovative practices in venous disease management and treatment. Operating from the United Kingdom, tasked with a mission to advance the scientific understanding and clinical practice surrounding venous disorders, PHLEBOLOGY is currently ranked in the Q3 category for both Cardiology and Cardiovascular Medicine, as well as in Medicine (miscellaneous) for 2023. Its Scopus rank of #192 out of 387 highlights its commitment to excellence, ensuring that it reaches a respectable 50th percentile within its fields. Although it does not offer open access, the journal invites contributions from researchers, healthcare professionals, and students, fostering a community dedicated to improving patient outcomes and promoting evidence-based practices in venous health.

CVIR Endovascular is a pioneering journal published by SPRINGERNATURE, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. Established as an Open Access platform since 2018, this journal has become increasingly pivotal for disseminating high-quality research that bridges clinical practice and innovative imaging techniques. With a robust focus on minimally invasive therapies and advancements in endovascular procedures, CVIR Endovascular serves as an essential resource for researchers, professionals, and students alike. The journal is indexed in key databases and holds notable rankings within its categories, specifically achieving Q3 quartile status in both Cardiology and Cardiovascular Medicine and Radiology for 2023. This positions it as an influential publication in the ever-evolving landscape of cardiovascular research. As it converges through the years from 2018 to 2024, CVIR Endovascular continues to strive for excellence, aiming to provide a platform for innovative findings and best practices that can enhance the future of endovascular care.

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

Artery Research is an esteemed open access journal published by BMC in the United Kingdom, dedicated to advancing the field of vascular biology and cardiovascular medicine. Since its inception in 2006 and transitioning to an open access format in 2019, the journal has become a pivotal platform for disseminating high-quality research on arterial health, pathology, and the latest clinical advancements. With an impactful focus on anatomy, cardiology, and physiology, Artery Research holds a notable reputation within the global research community, ranked in the Q3 and Q4 category quartiles in its respective fields and reflected in its Scopus ranks. The journal aims to foster collaborations and discussions among researchers and practitioners by providing an accessible avenue for publishing pivotal findings and insights. As it continues to evolve through 2024 and beyond, Artery Research remains committed to enriching cardiovascular research and driving innovations toward better health outcomes.

Vascular Specialist International, published by the Korean Society of Vascular Surgery, serves as a pivotal platform in the field of vascular surgery and cardiovascular medicine. With an Open Access policy established since 2014, the journal encourages a broader dissemination of research findings to an international audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal, ISSN 2288-7970, is headquartered in South Korea and spans a significant publication back to its inception, focusing on advancing clinical practice and research in vascular health. In the 2023 rankings, it is positioned in quartile Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, reflecting its growing impact within the scientific community. Furthermore, it holds commendable Scopus rankings in both categories, indicating its relevance and contributions to the field. With a mission to enhance vascular surgery practices and improve patient outcomes worldwide, Vascular Specialist International stands as an essential resource for those dedicated to advancing the science and art of vascular healthcare.